The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
Open accessAbstract
The PML tumor suppressor is the founding component of the multiprotein nuclear structures known as PML nuclear bodies (PML-NBs), which control several cellular functions including apoptosis and antiviral effects. The ubiquitin specific protease USP7 (also called HAUSP) is known to associate with PML-NBs and to be a tight binding partner of two herpesvirus proteins that disrupt PML NBs. Here we investigated whether USP7 itself regulates PML-NBs. Silencing of USP7 was found to increase the number of PML-NBs, to increase the levels of PML protein and to inhibit PML polyubiquitylation in nasopharyngeal carcinoma cells. This effect of USP7 was independent of p53 as PML loss was observed in p53-null cells. PML-NBs disruption was induced by USP7 overexpression independently of its catalytic activity and was induced by either of the protein interaction domains of USP7, each of which localized to PML-NBs. USP7 also disrupted NBs formed from some single PML isoforms, most notably isoforms I and IV. CK2α and RNF4, which are known regulators of PML, were dispensable for USP7-associated PML-NB disruption. The results are consistent with a novel model of PML regulation where a deubiquitylase disrupts PML-NBs through recruitment of another cellular protein(s) to PML NBs, independently of its catalytic activity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
USP7 associates with PML bodies.
“USP7 also associates with PML bodies (Sarkari et al., 2011) and PML proteins are essential for USP7 to degrade POT1 (Episkopou et al., 2019).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Sarkari et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A marker for Stevens–Johnson syndrome
Chung, W., Chung, W., Hong, H., Hsih, M., Yang, L., Ho, H., Wu, J., & Chen, Y.-T. (2004) · Nature · doi:10.1038/428486a · Cited by 1,748 · see citing works
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,027 · see citing works
Field, J. M., Nikawa, J., Broek, D., MACDONALD, B. S., Rodgers, L., Wilson, I. A., Lerner, R. A., & Wigler, M. H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.5.2159 · Cited by 949 · see citing works
Mechanisms of action of arsenic trioxide.
Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J. W., & Waxman, S. (2002) · PubMed · Cited by 939 · see citing works
p53 ubiquitination: Mdm2 and beyond
Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924 · see citing works
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M., Shen, L., Plechanovová, A., Hattersley, N., Jaffray, E., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 837 · see citing works
Ishov, A. M., Sotnikov, A. G., Negorev, D. G., Vladimirova, O. V., Neff, N. F., Kamitani, T., Yeh, E. T. H., Strauss, J. F., & Maul, G. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.2.221 · Cited by 825 · see citing works
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804 · cited 1× · see citing works
“USP7 has also been widely studied as a regulator of the p53 tumor suppressor [26,27,28,29,30].”
BackgroundTRIM family proteins: retroviral restriction and antiviral defence
Nisole, S., Stoye, J. P., & Saïb, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1248 · Cited by 761 · see citing works
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Pérès, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 726 · see citing works
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · see citing works
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548 · see citing works
Everett, R. D., Meredith, M., Orr, A., Cross, A., Kathoria, M., & Parkinson, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1519 · Cited by 491 · see citing works
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
van der Horst, A., de Vries-Smits, A. M. M., Brenkman, A. B., van Triest, M. H., van den Broek, N. J. F., Colland, F., Maurice, M. M., & Burgering, B. M. T. (2006) · Nature Cell Biology · doi:10.1038/ncb1469 · Cited by 479 · see citing works
PML protein isoforms and the RBCC/TRIM motif
Jensen, K., Shiels, C., & Freemont, P. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204765 · Cited by 465 · see citing works
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Malakhova, O. A., Kim, K. I. I., Luo, J.-K., Zou, W., Kumar, K. G., Fuchs, S. Y., Shuai, K., & Zhang, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601149 · Cited by 430 · see citing works
Everett, R. D., Freemont, P. S., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 399 · see citing works
Disruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379 · see citing works
Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen 1
Saridakis, V., Sheng, Y., Sarkari, F., Holowaty, M. N., Shire, K., Nguyen, T., Zhang, R. G., Liao, J. C. C., Lee, W., Edwards, A. M., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.029 · Cited by 362 · see citing works
Self-citationHSV‐1 IE protein Vmw110 causes redistribution of PML.
Everett, R. D., & Maul, G. G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06835.x · Cited by 352 · see citing works
Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., Verbel, D., Cordon‐Cardo, C., & Pandolfi, P. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh043 · Cited by 331 · see citing works
Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T., & Orr, A. (2006) · Journal of Virology · doi:10.1128/jvi.00734-06 · Cited by 323 · see citing works
Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng, Y., Saridakis, V., Sarkari, F., Duan, S., Wu, T., Arrowsmith, C. H., & Frappier, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1067 · Cited by 315 · see citing works
Self-citationPML Is a Direct p53 Target that Modulates p53 Effector Functions
de Stanchina, E., Querido, E., Narita, M., Davuluri, R. V., Pandolfi, P. P., Ferbeyre, G., & Lowe, S. W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00062-0 · Cited by 312 · see citing works
A CK2-Dependent Mechanism for Degradation of the PML Tumor Suppressor
Scaglioni, P. P., Yung, T. M., Cai, L. F., Erdjument‐Bromage, H., Kaufman, A., Singh, B., Teruya‐Feldstein, J., Tempst, P., & Pandolfi, P. P. (2006) · Cell · doi:10.1016/j.cell.2006.05.041 · Cited by 293 · see citing works
Maul, G. G., & Everett, R. D. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-6-1223 · Cited by 279 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
GMP Synthetase Stimulates Histone H2B Deubiquitylation by the Epigenetic Silencer USP7
van der Knaap, J. A., Kumar, B. R. P., Moshkin, Y. M., Langenberg, K. P. S., Krijgsveld, J., Heck, A. J. R., Karch, F., & Verrijzer, C. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.013 · Cited by 258 · see citing works
Gong, L., & Yeh, E. T. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511658200 · Cited by 245 · see citing works
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231 · see citing works
Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303977200 · Cited by 228 · see citing works
Self-citationHAUSP is Required for p53 Destabilization
Cummins, J. M., & Vogelstein, B. (2004) · Cell Cycle · doi:10.4161/cc.3.6.924 · Cited by 188 · see citing works
Besche, H. C., Haas, W., Gygi, S. P., & Goldberg, A. L. (2009) · Biochemistry · doi:10.1021/bi802198q · Cited by 183 · see citing works
Protein Interaction Domains of the Ubiquitin-specific Protease, USP7/HAUSP
Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C. H., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307200200 · Cited by 182 · see citing works
Self-citationParkinson, J., & Everett, R. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10006-10017.2000 · Cited by 170 · see citing works
Characterization of Endogenous Human Promyelocytic Leukemia Isoforms
Condemine, W., Takahashi, Y., Zhu, J., Puvion-Dutilleul, F., Guégan, S., Janin, A., & de Thé, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3792 · Cited by 155 · see citing works
Sivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 153 · see citing works
Self-citationAn infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
Sun, Y., Hegamyer, G. A., Cheng, Y. J., Hildesheim, A., Chen, J. Y., Chen, I.-H., Cao, Y., Yao, K., & Colburn, N. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6516 · Cited by 143 · see citing works
Canning, M., Boutell, C., Parkinson, J., & Everett, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402885200 · Cited by 142 · see citing works
Boutell, C., Canning, M., Orr, A., & Everett, R. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12342-12354.2005 · Cited by 134 · see citing works
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M. N., Sheng, Y., & Frappier, L. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000624 · Cited by 115 · see citing works
Self-citationBoutell, C., Orr, A., & Everett, R. D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8686-8694.2003 · Cited by 107 · see citing works
Weisshaar, S. R., Keusekotten, K., Krause, A., Horst, C., Springer, H. M., Göttsche, K., Dohmen, R. J., & Praefcke, G. J. K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.08.008 · Cited by 105 · see citing works
PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication
Cuchet, D., Sykes, A., Nicolas, A., Orr, A., Murray, J., Sirma, H., Heeren, J., Bartelt, A., & Everett, R. D. (2010) · Journal of Cell Science · doi:10.1242/jcs.075390 · Cited by 105 · see citing works
New insights into the role of PML in tumour suppression
Salomoni, P., Ferguson, B. J., Wyllie, A., & Rich, T. (2008) · Cell Research · doi:10.1038/cr.2008.58 · Cited by 104 · see citing works
Epstein-Barr Virus Nuclear Antigen 1 Hijacks the Host Kinase CK2 To Disrupt PML Nuclear Bodies
Sivachandran, N., Cao, J. Y., & Frappier, L. (2010) · Journal of Virology · doi:10.1128/jvi.01183-10 · Cited by 100 · see citing works
Self-citationNathan, J. A., Sengupta, S., Wood, S. A., Admon, A., Markson, G., Sanderson, C. M., & Lehner, P. J. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00747.x · Cited by 97 · see citing works
Meredith, M., Orr, A., & Everett, R. D. (1994) · Virology · doi:10.1006/viro.1994.1209 · Cited by 85 · see citing works
Meredith, M., Orr, A., Elliott, M., & Everett, R. D. (1995) · Virology · doi:10.1006/viro.1995.1241 · Cited by 84 · see citing works
Gambacorta, M., Flenghi, L., Fagioli, M., Pileri, S. A., Leoncini, L., Bigerna, B., Pacini, R., Tanci, L. N., Pasqualucci, L., Ascani, S., et al. (1996) · Europe PMC (PubMed Central) · Cited by 80 · see citing works
SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies
Häkli, M., Karvonen, U., Jänne, O., & Palvimo, J. J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.029 · Cited by 74 · see citing works
Bousquet, M., Baudelet, É., Guèrin, F., Matondo, M., Uttenweiler‐Joseph, S., Burlet‐Schiltz, O., & Monsarrat, B. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800193-mcp200 · Cited by 68 · see citing works
Yamaguchi, T., Kimura, J., Miki, Y., & Yoshida, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706282200 · Cited by 64 · see citing works
Wang, S., & Frappier, L. (2009) · Journal of Virology · doi:10.1128/jvi.00931-09 · Cited by 53 · see citing works
Self-citationTargeting Promyelocytic Leukemia Protein: A Means to Regulating PML Nuclear Bodies
Reineke, E. L., & Kao, H. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.366 · Cited by 47 · see citing works
Everett, R. D., Young, D. F., Randall, R. E., & Orr, A. (2008) · Journal of Virology · doi:10.1128/jvi.00613-08 · Cited by 42 · see citing works
Ohbayashi, N., Kawakami, S., Muromoto, R., Togi, S., Ikeda, O., Kamitani, S., Sekine, Y., Honjoh, T., & Matsuda, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.179 · Cited by 24 · see citing works
Antrobus, R., & Boutell, C. (2008) · Virus Research · doi:10.1016/j.virusres.2008.05.017 · Cited by 15 · see citing works
Dissecting Roles of Ubiquitination in the p53 Pathway
Shan, J., Brooks, C. L., Kon, N., Li, M., & Gu, W. J. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_105 · Cited by 15 · see citing works
CK2 and PML: Regulating the Regulator
Lallemand-Breitenbach, V., & de Thé, H. (2006) · Cell · doi:10.1016/j.cell.2006.07.004 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Epstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. D. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 359 · see citing works
Differential Roles of PML Isoforms
Nisole, S., Maroui, M. A., Mascle, X. H., Aubry, M., & Chelbi‐Alix, M. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00125 · Cited by 168 · see citing works
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.
Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0012-y · Cited by 162 · see citing works
Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
Frappier, L. (2012) · Viruses · doi:10.3390/v4091537 · Cited by 127 · see citing works
Self-citationFunctions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection
Sivachandran, N., Wang, X., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.00013-12 · Cited by 124 · see citing works
Self-citationUSP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
“USP7 also associates with PML bodies (Sarkari et al., 2011) and PML proteins are essential for USP7 to degrade POT1 (Episkopou et al.”
BackgroundUSP7 - a crucial regulator of cancer hallmarks
Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188903 · Cited by 106 · see citing works
The Epstein-Barr Virus EBNA1 Protein
Frappier, L. (2012) · Scientifica · doi:10.6064/2012/438204 · Cited by 97 · see citing works
Self-citationContributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Sivachandran, N., Dawson, W. O., Young, L. S., Liu, F., Middeldorp, J. M., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05623-11 · Cited by 95 · see citing works
Self-citationGuan, D., Factor, D. C., Liu, Y., Wang, Z., & Kao, H.-Y. (2012) · Oncogene · doi:10.1038/onc.2012.406 · Cited by 90 · see citing works
Frappier, L. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_1 · Cited by 78 · see citing works
Self-citationSalsman, J., Jagannathan, M., Paladino, P., Chan, P.-K., Dellaire, G., Raught, B., & Frappier, L. (2011) · Journal of Virology · doi:10.1128/jvi.05442-11 · Cited by 73 · see citing works
Self-citationPfoh, R., Lacdao, I. K., Georges, A. A., Capar, A., Zheng, H. X., Frappier, L., & Saridakis, V. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004950 · Cited by 72 · see citing works
Self-citationA role for USP7 in DNA replication.
Jagannathan, M., Nguyen, T., Gallo, D., Luthra, N., Brown, G. W., Saridakis, V., & Frappier, L. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00639-13 · Cited by 71 · see citing works
Self-citationIdentification and Characterization of USP7 Targets in Cancer Cells
Georges, A. A., Marcon, E., Greenblatt, J. F., & Frappier, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-34197-x · Cited by 63 · see citing works
Self-citationGene expression control by protein deubiquitinases
Frappier, L., & Verrijzer, C. P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.005 · Cited by 58 · see citing works
Self-citationEpigenetic regulation of EBV and KSHV latency
Chen, H.-S., Lu, F. Y., & Lieberman, P. M. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.004 · Cited by 57 · see citing works
Episkopou, H., Diman, A., Claude, E., Viceconte, N., & Decottignies, A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.027 · Cited by 55 · see citing works
Liu, J. C. Y., Ackermann, L., Hoffmann, S., Gál, Z., Hendriks, I. A., Jain, C., Morlot, L., Tatham, M. H., McLelland, G., Hay, R. T., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01294-7 · Cited by 54 · see citing works
USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein
Ali, A., Raja, R., Farooqui, S. R., Ahmad, S., & Banerjea, A. C. (2017) · Biochemical Journal · doi:10.1042/bcj20160304 · Cited by 54 · see citing works
African swine fever virus replication events and cell nucleus: New insights and perspectives
Simões, M., Freitas, F. B., Leitão, A., Martins, C. L. V., & Ferreira, F. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197667 · Cited by 53 · see citing works
Geng, Y., Monajembashi, S., Shao, A., Cui, D., He, W., Chen, Z., Hemmerich, P. H., & Tang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374769 · Cited by 49 · see citing works
Chavoshi, S., Egorova, O., Lacdao, I. K., Farhadi, S., Sheng, Y., & Saridakis, V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710632 · Cited by 49 · see citing works
Identification of Herpesvirus Proteins That Contribute to G 1 /S Arrest
Paladino, P., Marcon, E., Greenblatt, J. F., & Frappier, L. (2014) · Journal of Virology · doi:10.1128/jvi.00059-14 · Cited by 48 · see citing works
Self-citationUbiquitin-specific Protease 7 Is a Regulator of Ubiquitin-conjugating Enzyme UbE2E1
Sarkari, F., Wheaton, K., Delfa, A. L., Mohamed, M., Shaikh, F., Khatun, R., Arrowsmith, C. H., Frappier, L., Saridakis, V., & Sheng, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469262 · Cited by 47 · see citing works
Self-citationChing, W., Koyuncu, E., Singh, S. K., Arbelo-Roman, C., Härtl, B., Kremmer, E., Speiseder, T., Meier, C., & Dobner, T. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003273 · Cited by 47 · see citing works
Chromatin Structure of Epstein–Barr Virus Latent Episomes
Lieberman, P. M. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_5 · Cited by 47 · see citing works
Simões, M., Rino, J., Pinheiro, I., Martins, C. L. V., & Ferreira, F. (2015) · Viruses · doi:10.3390/v7092858 · Cited by 43 · see citing works
Gillen, J., Li, W., Liang, Q., Avey, D. R., Wu, J., Wu, F., Myoung, J., & Zhu, F. (2015) · Journal of Virology · doi:10.1128/jvi.02925-14 · Cited by 39 · see citing works
USP7 Regulates Cytokinesis through FBXO38 and KIF20B
Georges, A. A., Coyaud, É., Marcon, E., Greenblatt, J. F., Raught, B., & Frappier, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39368-y · Cited by 38 · see citing works
Self-citationUSP7 manipulation by viral proteins
Bojagora, A., & Saridakis, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198076 · Cited by 33 · see citing works
Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges
Jin, W., Mao, X., & Qiu, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21421 · Cited by 32 · see citing works
Xiang, Q., Ju, H., Li, Q., Mei, S.-C., Chen, D., Choi, Y. B., & Nicholas, J. (2018) · Journal of Virology · doi:10.1128/jvi.02003-17 · Cited by 31 · see citing works
HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP
Bhattacharya, S., & Ghosh, M. K. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0228-6 · Cited by 31 · see citing works
USP7/HAUSP Promotes the Sequence-Specific DNA Binding Activity of p53
Sarkari, F., Sheng, Y., & Frappier, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013040 · Cited by 30 · see citing works
Self-citationIncoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes
Bienkowska‐Haba, M., Łuszczek, W., Keiffer, T. R., Guion, L. G. M., DiGiuseppe, S., Scott, R. S., & Sapp, M. J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12708 · Cited by 27 · see citing works
Identification of RNF168 as a PML nuclear body regulator
Shire, K., Wong, A. I., Tatham, M. H., Anderson, O. F., Ripsman, D., Gulstene, S., Moffat, J., Hay, R. T., & Frappier, L. (2015) · Journal of Cell Science · doi:10.1242/jcs.176446 · Cited by 22 · see citing works
Self-citationKalamvoki, M., Gu, H., & Roizman, B. (2012) · Journal of Virology · doi:10.1128/jvi.01981-12 · Cited by 17 · see citing works
The PML hub: An emerging actor of leukemia therapies
Rérolle, D., & de Thé, H. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221213 · Cited by 16 · see citing works
HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response
Das, S., Chandrasekaran, A. P., Jo, K.-S., Ko, N. R., Oh, S. J., Kim, K.-S., & Ramakrishna, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118835 · Cited by 16 · see citing works
Epstein-Barr Virus and the Pathogenesis of Nasopharyngeal Carcinomas
Gourzonès, C., Busson, P., & Raab‐Traub, N. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5947-7_4 · Cited by 15 · see citing works
Chandra, P., & Philips, J. A. (2024) · Autophagy · doi:10.1080/15548627.2024.2395134 · Cited by 13 · see citing works
HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG
Cheng, C., Dong, Y., Niu, W., & Niu, C. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152883 · Cited by 13 · see citing works
Sun, H., Chen, G., Guo, B., Lv, S., & Yuan, G. (2023) · Journal of Cancer · doi:10.7150/jca.80097 · Cited by 11 · see citing works
Mansouri, S., Wang, S., & Frappier, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063802 · Cited by 11 · see citing works
Self-citationBarbeito, P., Martin-Morales, R., Palencia‐Campos, A., Cerrolaza, J., Rivas-Santos, C., Gallego-Colastra, L., Caparros-Martin, J. A., Martin-Bravo, C., Martín-Hurtado, A., Sánchez-Bellver, L., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1190258 · Cited by 10 · see citing works
Frappier, L. (2025) · Current topics in microbiology and immunology · doi:10.1007/82_2025_299 · Cited by 5 · see citing works
Self-citationManipulation of PML Nuclear Bodies and DNA Damage Responses by DNA Viruses
Frappier, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_13 · Cited by 4 · see citing works
Self-citationRotavirus NSP1 localizes in the nucleus to disrupt PML nuclear bodies during infectionPreprint
Murphy, S. K., & Arnold, M. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/619932 · Cited by 4 · see citing works
USP7 at PML Nuclear Bodies: A Protein Interaction Network Perspective
Silonov, S. A., Ведешкина, Е., Mokin, Y. I., Sukailo, D. A., Smirnov, E. Y., Reushev, V. A., Константинович, Т. К., Константинович, Т. К., & Fonin, A. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27094106 · Cited by 1 · see citing works
TRIM27 in HSV-1 Infection: A Story of Loss and Death
Conwell, S. E. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Frappier, L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6886-8_5
Self-citationGao, L. (2015) · OHSU Digital Commons · doi:10.6083/m44q7s0g
Pozhidaeva, A. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
Landry, C. H. (2013) · TSpace (University of Toronto)
Identification of new regulators for PML nuclear bodies
Snollaerts, T. (2016) · theses.fr (ABES) · doi:10.70675/a97a0132zae2fz4278zad92z5e4b56df97b2
A study on the role of PML in acute myeloid leukemia response to chemotherapy
Rérolle, D. (2024) · theses.fr (ABES) · doi:10.70675/b8e14224z7fb4z48a1zbe13zbd80a1788e94
- Authors
- Sarkari, F., Wang, X., Nguyen, T., & Frappier, L.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Frappier, Lori
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-01-31
- Volume
- 6
- Issue
- 1
- Pages
- e16598
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3031599
- OpenAlex
- W2088620741
- Cited by
- 59
- References
- 60
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 1 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1 · 2016: 6 · 2015: 10 · 2014: 1 · 2013: 9 · 2012: 7
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Canadian Institutes of Health Research (93652)
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- USP7, PML nuclear bodies, PML, deubiquitination, ubiquitin-specific protease, PML isoforms, CK2α, RNF4, p53-independent regulation, nasopharyngeal carcinoma, protein-protein interaction domains
- MeSH terms
- Promyelocytic Leukemia Protein, Ubiquitin-Specific Peptidase 7, Nasopharyngeal Carcinoma, Carcinoma, Gene Expression Regulation, Herpesviridae, Humans, Nasopharyngeal Neoplasms, Nuclear Proteins, Endopeptidases, Protein Binding, Transcription Factors, Tumor Suppressor Protein p53, Protein Isoforms, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Intranuclear Inclusion Bodies, Cell Line, Tumor, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review